Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).

PMID: 198417392009

Key Findings

Imatinib and nilotinib reverse MRP7-mediated multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 transporter.

1gene entry

0mutation entries

AMR Genes

Gene Name	Alleles	Encodes	Confers Resistance To	Organisms	Database	Validation Status
mrp7	1	ATP-binding cassette sub-family C member 10	-	-	Reslit	-